Skip to main content

Growth Hormone Suppression Test (Post-Glucose Administration)

  • Chapter
  • First Online:
  • 1255 Accesses

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Subbarayan SK, Fleseriu M, Gordon MB, et al. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocr Pract. 2012;18(6):817–25.

    Article  PubMed  Google Scholar 

  2. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK. American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update. Endocr Pract. 2011;17:1–44.

    Article  PubMed  Google Scholar 

  3. Minuto F, Resmini E, Boschetti M, et al. Assessment of disease activity in acromegaly by means of a single blood sample: Comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clin Endocrinol (Oxf). 2004;61(1):138–44.

    Article  CAS  Google Scholar 

  4. Melmed S, Casanueva F, Cavagnini F, et al. Consensus statement: Medical management of acromegaly. Eur J Endocrinol . 2005;153(6):737–40.

    Article  CAS  PubMed  Google Scholar 

  5. Dobri GA, Faiman C, Kennedy L, et al. Is the GH Nadir value during OGTT reliable in diagnosing acromegaly in patients with altered glucose metabolism? Poster Board SAT-128, Endo 2013. https://Endo.confex.com/endo/2013endo/webprogram/Paper7607.html.

  6. Hattori N, Shimatsu A, Kato Y, et al. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. J Clin Endocrinol Metab. 1990;70(3):771–6.

    Article  CAS  PubMed  Google Scholar 

  7. Earll JM, Sparks LL, Forsham PH. Glucose suppression of serum growth hormone in the diagnosis of acromegaly. JAMA. 1967;201(8):628–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmet Bahadir Ergin .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ergin, A., Hamrahian, A., Kennedy, A., Gupta, M. (2015). Growth Hormone Suppression Test (Post-Glucose Administration). In: The Cleveland Clinic Manual of Dynamic Endocrine Testing. Springer, Cham. https://doi.org/10.1007/978-3-319-13048-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13048-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13047-7

  • Online ISBN: 978-3-319-13048-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics